Literature DB >> 7812356

Increased oxygen tensions influence subset composition of the cellular immune system in aged mice.

A K Lee1, R B Hester, J H Coggin, S F Gottlieb.   

Abstract

In acute and chronic experiments, each of eight groups of aged mice were assigned separately to different pressures of oxygen to which it was to be exposed. Lymphocytes from spleen, thymus, and peripheral blood were analyzed following oxygen exposure. Subset populations changed depending on the oxygen tension. Variable changes were observed in total numbers of lymphocytes, lymphocyte subsets, B cells, and macrophages depending on the organ studied and the oxygen pressure to which the mice were exposed. There were differences between acute and chronic exposure suggestive of adaptation to environmental stressors. The suggestion is made that the immune system has a reserve capacity that can be influenced by oxygen and, thereby, theoretically capable of being pharmacologically manipulated to assist patients with altered immune systems to promote defense mechanisms or, under certain circumstances, reduce autoimmunity. It is hypothesized that an underlying hypoxia may be involved in the age-associated decline in the immune system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812356     DOI: 10.1089/cbr.1994.9.39

Source DB:  PubMed          Journal:  Cancer Biother        ISSN: 1062-8401


  2 in total

1.  Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages.

Authors:  N Lahat; H Bitterman; N Yaniv; A Kinarty; N Bitterman
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

2.  Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy.

Authors:  Gaetano Faleo; Carmen Fotino; Nicola Bocca; R Damaris Molano; Elsie Zahr-Akrawi; Judith Molina; Susana Villate; Oliver Umland; Jay S Skyler; Allison L Bayer; Camillo Ricordi; Antonello Pileggi
Journal:  Diabetes       Date:  2012-05-07       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.